ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Circulating Tumor Cell(CTC)Detection Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-3E18543
Home | Market Reports | Health| Health Conditions| Cancer
Global Circulating Tumor Cell CTC Detection Market Research Report 2024
BUY CHAPTERS

Global Circulating Tumor Cell(CTC)Detection Market Research Report 2026

Code: QYRE-Auto-3E18543
Report
2026-02-10
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
RareCyte
Angle plc
Biocept
Bio-Rad Laboratories Inc
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen NV

Circulating Tumor Cell(CTC)Detection Market

The global Circulating Tumor Cell(CTC)Detection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The free tumor cell (CTC) test is a method used to detect and analyze tumor cells circulating in the blood. CTCs are cancer cells that fall off from the primary tumor and enter the blood circulation. By detecting these cells, important information about cancer progression, metastasis risk, and treatment efficacy can be provided. CTC detection is a non-invasive liquid biopsy technology that can monitor the development of cancer in real time and help doctors optimize personalized treatment plans. It is particularly suitable for early diagnosis of cancer, prediction of recurrence, and efficacy evaluation.
The North American market for Circulating Tumor Cell(CTC)Detection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Circulating Tumor Cell(CTC)Detection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Circulating Tumor Cell(CTC)Detection in Cancer Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Circulating Tumor Cell(CTC)Detection include Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Circulating Tumor Cell(CTC)Detection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Circulating Tumor Cell(CTC)Detection. The Circulating Tumor Cell(CTC)Detection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Circulating Tumor Cell(CTC)Detection market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Circulating Tumor Cell(CTC)Detection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Circulating Tumor Cell(CTC)Detection Market Report

Report Metric Details
Report Name Circulating Tumor Cell(CTC)Detection Market
Segment by Type
  • Epithelial Cell Phenotype
  • Mesenchymal Cell Phenotype
  • Mixed Epithelial-Mesenchymal Phenotype
Segment by Application
  • Cancer Diagnosis
  • Tumor Dynamic Assessment
  • Tumor Recurrence Monitoring
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Circulating Tumor Cell(CTC)Detection companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The main players in the Circulating Tumor Cell(CTC)Detection Market are Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen

What are the Application segmentation covered in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The Applications covered in the Circulating Tumor Cell(CTC)Detection Market report are Cancer Diagnosis, Tumor Dynamic Assessment, Tumor Recurrence Monitoring

What are the Type segmentation covered in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The Types covered in the Circulating Tumor Cell(CTC)Detection Market report are Epithelial Cell Phenotype, Mesenchymal Cell Phenotype, Mixed Epithelial-Mesenchymal Phenotype

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Epithelial Cell Phenotype
1.2.3 Mesenchymal Cell Phenotype
1.2.4 Mixed Epithelial-Mesenchymal Phenotype
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell(CTC)Detection Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer Diagnosis
1.3.3 Tumor Dynamic Assessment
1.3.4 Tumor Recurrence Monitoring
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell(CTC)Detection Market Perspective (2021–2032)
2.2 Global Circulating Tumor Cell(CTC)Detection Growth Trends by Region
2.2.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Circulating Tumor Cell(CTC)Detection Historic Market Size by Region (2021–2026)
2.2.3 Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Region (2027–2032)
2.3 Circulating Tumor Cell(CTC)Detection Market Dynamics
2.3.1 Circulating Tumor Cell(CTC)Detection Industry Trends
2.3.2 Circulating Tumor Cell(CTC)Detection Market Drivers
2.3.3 Circulating Tumor Cell(CTC)Detection Market Challenges
2.3.4 Circulating Tumor Cell(CTC)Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell(CTC)Detection Players by Revenue
3.1.1 Global Top Circulating Tumor Cell(CTC)Detection Players by Revenue (2021–2026)
3.1.2 Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Players (2021–2026)
3.2 Global Top Circulating Tumor Cell(CTC)Detection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cell(CTC)Detection Revenue
3.4 Global Circulating Tumor Cell(CTC)Detection Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell(CTC)Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell(CTC)Detection Revenue in 2025
3.5 Global Key Players of Circulating Tumor Cell(CTC)Detection Head Offices and Areas Served
3.6 Global Key Players of Circulating Tumor Cell(CTC)Detection, Products and Applications
3.7 Global Key Players of Circulating Tumor Cell(CTC)Detection, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Circulating Tumor Cell(CTC)Detection Breakdown Data by Type
4.1 Global Circulating Tumor Cell(CTC)Detection Historic Market Size by Type (2021–2026)
4.2 Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Type (2027–2032)
5 Circulating Tumor Cell(CTC)Detection Breakdown Data by Application
5.1 Global Circulating Tumor Cell(CTC)Detection Historic Market Size by Application (2021–2026)
5.2 Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Circulating Tumor Cell(CTC)Detection Market Size (2021–2032)
6.2 North America Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021–2026)
6.4 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell(CTC)Detection Market Size (2021–2032)
7.2 Europe Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2021–2026)
7.4 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size (2021–2032)
8.2 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2021–2026)
8.4 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circulating Tumor Cell(CTC)Detection Market Size (2021–2032)
9.2 Latin America Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021–2026)
9.4 Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size (2021–2032)
10.2 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2021–2026)
10.4 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Rarecyte
11.1.1 Rarecyte Company Details
11.1.2 Rarecyte Business Overview
11.1.3 Rarecyte Circulating Tumor Cell(CTC)Detection Introduction
11.1.4 Rarecyte Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.1.5 Rarecyte Recent Development
11.2 ANGLE plc
11.2.1 ANGLE plc Company Details
11.2.2 ANGLE plc Business Overview
11.2.3 ANGLE plc Circulating Tumor Cell(CTC)Detection Introduction
11.2.4 ANGLE plc Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.2.5 ANGLE plc Recent Development
11.3 Biocept Inc.
11.3.1 Biocept Inc. Company Details
11.3.2 Biocept Inc. Business Overview
11.3.3 Biocept Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.3.4 Biocept Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.3.5 Biocept Inc. Recent Development
11.4 Bio-Rad Laboratories Inc.
11.4.1 Bio-Rad Laboratories Inc. Company Details
11.4.2 Bio-Rad Laboratories Inc. Business Overview
11.4.3 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.4.4 Bio-Rad Laboratories Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.4.5 Bio-Rad Laboratories Inc. Recent Development
11.5 Fluxion Biosciences Inc.
11.5.1 Fluxion Biosciences Inc. Company Details
11.5.2 Fluxion Biosciences Inc. Business Overview
11.5.3 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.5.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.5.5 Fluxion Biosciences Inc. Recent Development
11.6 F. Hoffmann-La Roche AG
11.6.1 F. Hoffmann-La Roche AG Company Details
11.6.2 F. Hoffmann-La Roche AG Business Overview
11.6.3 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Introduction
11.6.4 F. Hoffmann-La Roche AG Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.6.5 F. Hoffmann-La Roche AG Recent Development
11.7 Sysmex Europe SE
11.7.1 Sysmex Europe SE Company Details
11.7.2 Sysmex Europe SE Business Overview
11.7.3 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Introduction
11.7.4 Sysmex Europe SE Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.7.5 Sysmex Europe SE Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Circulating Tumor Cell(CTC)Detection Introduction
11.8.4 Qiagen Revenue in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
11.8.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
RareCyte
Angle plc
Biocept
Bio-Rad Laboratories Inc
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen NV
List of Tables
 Table 1. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Epithelial Cell Phenotype
 Table 3. Key Players of Mesenchymal Cell Phenotype
 Table 4. Key Players of Mixed Epithelial-Mesenchymal Phenotype
 Table 5. Global Circulating Tumor Cell(CTC)Detection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2021–2026)
 Table 9. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2027–2032)
 Table 11. Circulating Tumor Cell(CTC)Detection Market Trends
 Table 12. Circulating Tumor Cell(CTC)Detection Market Drivers
 Table 13. Circulating Tumor Cell(CTC)Detection Market Challenges
 Table 14. Circulating Tumor Cell(CTC)Detection Market Restraints
 Table 15. Global Circulating Tumor Cell(CTC)Detection Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Circulating Tumor Cell(CTC)Detection Market Share by Players (2021–2026)
 Table 17. Global Top Circulating Tumor Cell(CTC)Detection Players by Tier (Tier 1, Tier 2, and Tier 3), based on Circulating Tumor Cell(CTC)Detection Revenue, 2025
 Table 18. Ranking of Global Top Circulating Tumor Cell(CTC)Detection Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell(CTC)Detection Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Circulating Tumor Cell(CTC)Detection, Headquarters and Area Served
 Table 21. Global Key Players of Circulating Tumor Cell(CTC)Detection, Products and Applications
 Table 22. Global Key Players of Circulating Tumor Cell(CTC)Detection, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Circulating Tumor Cell(CTC)Detection Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2021–2026)
 Table 26. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2027–2032)
 Table 28. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2021–2026)
 Table 30. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2027–2032)
 Table 32. North America Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (US$ Million), 2027–2032
 Table 47. Rarecyte Company Details
 Table 48. Rarecyte Business Overview
 Table 49. Rarecyte Circulating Tumor Cell(CTC)Detection Product
 Table 50. Rarecyte Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 51. Rarecyte Recent Development
 Table 52. ANGLE plc Company Details
 Table 53. ANGLE plc Business Overview
 Table 54. ANGLE plc Circulating Tumor Cell(CTC)Detection Product
 Table 55. ANGLE plc Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 56. ANGLE plc Recent Development
 Table 57. Biocept Inc. Company Details
 Table 58. Biocept Inc. Business Overview
 Table 59. Biocept Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 60. Biocept Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 61. Biocept Inc. Recent Development
 Table 62. Bio-Rad Laboratories Inc. Company Details
 Table 63. Bio-Rad Laboratories Inc. Business Overview
 Table 64. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 65. Bio-Rad Laboratories Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 66. Bio-Rad Laboratories Inc. Recent Development
 Table 67. Fluxion Biosciences Inc. Company Details
 Table 68. Fluxion Biosciences Inc. Business Overview
 Table 69. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 70. Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 71. Fluxion Biosciences Inc. Recent Development
 Table 72. F. Hoffmann-La Roche AG Company Details
 Table 73. F. Hoffmann-La Roche AG Business Overview
 Table 74. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product
 Table 75. F. Hoffmann-La Roche AG Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 76. F. Hoffmann-La Roche AG Recent Development
 Table 77. Sysmex Europe SE Company Details
 Table 78. Sysmex Europe SE Business Overview
 Table 79. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product
 Table 80. Sysmex Europe SE Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 81. Sysmex Europe SE Recent Development
 Table 82. Qiagen Company Details
 Table 83. Qiagen Business Overview
 Table 84. Qiagen Circulating Tumor Cell(CTC)Detection Product
 Table 85. Qiagen Revenue in Circulating Tumor Cell(CTC)Detection Business (US$ Million), 2021–2026
 Table 86. Qiagen Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Circulating Tumor Cell(CTC)Detection Picture
 Figure 2. Global Circulating Tumor Cell(CTC)Detection Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Circulating Tumor Cell(CTC)Detection Market Share by Type: 2025 vs 2032
 Figure 4. Epithelial Cell Phenotype Features
 Figure 5. Mesenchymal Cell Phenotype Features
 Figure 6. Mixed Epithelial-Mesenchymal Phenotype Features
 Figure 7. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Circulating Tumor Cell(CTC)Detection Market Share by Application: 2025 vs 2032
 Figure 9. Cancer Diagnosis Case Studies
 Figure 10. Tumor Dynamic Assessment Case Studies
 Figure 11. Tumor Recurrence Monitoring Case Studies
 Figure 12. Circulating Tumor Cell(CTC)Detection Report Years Considered
 Figure 13. Global Circulating Tumor Cell(CTC)Detection Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Circulating Tumor Cell(CTC)Detection Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Circulating Tumor Cell(CTC)Detection Market Share by Region: 2025 vs 2032
 Figure 16. Global Circulating Tumor Cell(CTC)Detection Market Share by Players in 2025
 Figure 17. Global Circulating Tumor Cell(CTC)Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cell(CTC)Detection Revenue in 2025
 Figure 19. North America Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Circulating Tumor Cell(CTC)Detection Market Share by Country (2021–2032)
 Figure 21. United States Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Circulating Tumor Cell(CTC)Detection Market Share by Country (2021–2032)
 Figure 25. Germany Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Share by Region (2021–2032)
 Figure 33. China Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Circulating Tumor Cell(CTC)Detection Market Share by Country (2021–2032)
 Figure 41. Mexico Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Country (2021–2032)
 Figure 45. Israel Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Rarecyte Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 49. ANGLE plc Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 50. Biocept Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 51. Bio-Rad Laboratories Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 52. Fluxion Biosciences Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 53. F. Hoffmann-La Roche AG Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 54. Sysmex Europe SE Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 55. Qiagen Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2021–2026)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Free Circulating Tumor Cell Detection Market Research Report 2024
Global CTC Detection Market Research Report 2025
Global Circulating Tumor Cells CTCs Detectors Market Research Report 2024
Global Circulating Tumor Cell Diagnostics Market Insights Forecast to 2030
Global Circulating Tumor Cell CTC Detector Market Research Report 2024
Circulating Tumor Cell Capture Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Circulating Tumor Cell Detection System Market Research Report 2024
Global Cell free Tumor DNA Detection Market Research Report 2025
Global Circulating Tumor Cells Market Research Report 2025
Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2024
Circulating Tumor Cell CTC Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ctDNA Detection Market Research Report 2025
Global Circulating Tumor Cells CTCs and Cancer Stem Cells CSCs Market Insights Forecast to 2030
Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ctDNA Detection Kit Market Research Report 2024
Global Circulating Tumor DNA Diagnostics Market Research Report 2025
Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Circulating Tumour DNA ctDNA Testing Market Research Report 2024
Global Cell Free Circulating Tumor DNA ctDNA Market Research Report 2024
Global Liquid Biopsy Products Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions